A. Xhaard

发表

CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.

M. Robin, M. Rybojad, R. Itzykson, 2015, Blood.

The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients

P. Fenaux, P. Tiberghien, M. Sébert, 2022, Vox sanguinis.

GLCCI1 and Glucocorticoid Receptor Genetic Diversity and Response to Glucocorticoid-Based Treatment of Graft-versus-Host Disease.

M. Robin, R. Tamouza, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study

F. Roudot-thoraval, D. Klatzmann, G. Socié, 2014, Leukemia.

Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation

M. Robin, D. Valla, P. Bourrier, 2020, Haematologica.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

R. Porcher, M. Robin, I. Casin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study

M. Darmon, G. Socié, J. Molina, 2022, Bone Marrow Transplantation.

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

R. Porcher, M. Robin, G. Socié, 2015, Blood.

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

S. Iacobelli, T. Pabst, P. Ljungman, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.

S. Maiella, J. Larghero, L. Rogge, 2013, Blood.

graft-versus-host disease T-cell populations in homeostatic conditions and during regulatory + FOXP3 + Multiparameter single-cell profiling of human CD4

S. Maiella, J. Larghero, L. Rogge, 2013 .

TRANSPLANTATION CD24 hi CD27 1 and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

M. Robin, M. Rybojad, R. Itzykson, 2015 .

Anti–Angiotensin Type 1 Receptor Antibodies in Chronic Graft-Versus-Host Disease

M. Robin, A. Toubert, M. Carmagnat, 2014, Transplantation.

Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report

M. Robin, G. Socié, N. Parquet, 2020, Annals of Hematology.

Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study

M. Darmon, E. Lengliné, J. Cornillon, 2015, Respiration.

High number of memory t cells is associated with higher risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

R. Porcher, M. Robin, V. Vanneaux, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human-derived α1-antitrypsin is still efficacious in heavily pretreated patients with steroid-resistant gastrointestinal graft-versus-host disease.

M. Robin, G. Socié, N. Dhédin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

M. Robin, N. Young, J. Larghero, 2011, Blood.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

R. Porcher, M. Mohty, G. Socié, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study

P. Rohrlich, V. Mallet, A. Roque-Afonso, 2019, Viruses.

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

H. Dombret, M. Robin, P. Fenaux, 2020, Leukemia.

Legionellosis after hematopoietic stem cell transplantation

J. Bourhis, D. Blaise, C. Crawley, 2021, Bone Marrow Transplantation.

Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation

M. Robin, L. Adès, G. Socié, 2022, Bone Marrow Transplantation.

Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD

M. Robin, N. Kapel, G. Socié, 2015, Bone Marrow Transplantation.

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

R. Porcher, M. Robin, S. Thépot, 2010, Leukemia.

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation

M. Robin, A. Toubert, M. Carmagnat, 2014, Haematologica.

Outcomes in critically ill chronic lymphocytic leukemia patients

É. Azoulay, M. Darmon, L. Epelboin, 2013, Supportive Care in Cancer.

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

J. Bourhis, M. Robin, M. Rybojad, 2012, Blood.

Optimization of health-care organization and perceived improvement of patient comfort by switching from intra-venous BU four-times-daily infusions to a once-daily administration scheme in adult hematopoietic stem cell recipients

S. Santarone, C. Scheid, W. Krüger, 2014, Bone Marrow Transplantation.

The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults

A. Baruchel, M. Robin, T. Leblanc, 2018, British journal of haematology.

Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation

M. Robin, A. Toubert, R. Itzykson, 2015, Haematologica.

Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.

M. Robin, G. Socié, D. Michonneau, 2019, Blood advances.

Hepatic GVHD leading to cirrhosis after allogeneic hematopoietic SCT

M. Robin, P. Nahon, L. Adès, 2012, Bone Marrow Transplantation.

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

B. Autran, Y. Yazdanpanah, J. Gottenberg, 2022, Journal of Infection.

Viral Respiratory Infections Diagnosed by Multiplex PCR after Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Incidence and Outcome

R. Porcher, M. Robin, G. Socié, 2014, Biology of Blood and Marrow Transplantation.

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.

M. Robin, L. Biard, M. Resche-Rigon, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Late donor bone marrow failure after allogeneic hematopoietic stem cell transplantation.

M. Robin, G. Socié, N. Dhédin, 2014, Transplantation.

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT.

M. Robin, R. Calado, M. Busson, 2017, Blood advances.

Prevalence and causes of burnout amongst oncology residents: a comprehensive nationwide cross-sectional study.

Y. Loriot, D. Truchot, S. Dewas, 2010, European journal of cancer.

Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.

M. Robin, N. Boissel, C. Poirot, 2021, Transplantation and cellular therapy.

Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital

C. Delaugerre, S. Chevret, M. Sébert, 2021, Blood Cancer Journal.

J. Bourhis, M. Robin, M. Rybojad, 2014, The British journal of dermatology.

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

N. Kröger, P. Ljungman, S. Mielke, 2021, Leukemia.

Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort Study.

M. Robin, P. Bedossa, G. Socié, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.

R. Porcher, M. Robin, A. Toubert, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

R. Porcher, J. Cayuela, M. Robin, 2012, Haematologica.

Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study

M. Robin, J. Bay, C. Xhaard, 2021, British Journal of Haematology.

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

M. Robin, D. Weisdorf, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML

R. Porcher, H. Dombret, M. Robin, 2015, Bone Marrow Transplantation.

Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.

R. Porcher, M. Robin, N. Kapel, 2012, Blood.

Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program.

P. Chevallier, I. Yakoub-Agha, A. Thiébaut, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study

C. Solano, E. Holler, C. Junghanss, 2020, Bone Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of the source of hematopoietic stem cell in unrelated transplants: Comparison between 10/10, 9/10‐HLA matched donors and cord blood

R. Porcher, M. Robin, J. Larghero, 2015, American journal of hematology.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC

J. Bay, B. Neven, G. Socié, 2015, Transplantation.

EBV-associated post-transplant lymphoproliferative disease in patients who received anti-CD 20 after hematopoietic stem cell transplantation.

M. Robin, V. Meignin, G. Socié, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Splenectomy in Myelofibrosis Patients before Allogeneic Hematopoietic Stem Cell Transplantation.

S. Chevret, M. Robin, V. Meignin, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study.

U. Spengler, A. Lohse, R. D. de Man, 2019, Journal of hepatology.

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors

R. Porcher, M. Robin, J. Larghero, 2014, Haematologica.

R. Porcher, H. Dombret, M. Robin, 2013, Bone Marrow Transplantation.

Impact of comorbidity indexes on non-relapse mortality

R. Porcher, M. Robin, G. Socié, 2008, Leukemia.

Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation.

C. Picard, P. Chevallier, C. Elie, 2016, The Journal of allergy and clinical immunology.

The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.

S. Chevret, M. Robin, A. Janin, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT

M. Robin, A. Toubert, M. Busson, 2014, Bone Marrow Transplantation.

Case report: Central nervous system involvement of human graft versus host disease

M. Robin, V. Meignin, K. Mokhtari, 2017, Medicine.

Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.

M. Robin, G. Socié, V. Rocha, 2010, Transplantation.

Expansion of circulating CD49b+LAG3+ type 1 regulatory T (Tr1) cells in human chronic graft-versus-host disease.

M. Robin, M. Rybojad, M. Bagot, 2020, The Journal of investigative dermatology.

Expansion of Circulating CD49b Regulatory T Cells in Human Chronic Graft-Versus-Host Disease

M. Robin, M. Rybojad, M. Bagot, 2020 .

Fully Automated Quantification of Cytomegalovirus (CMV) in Whole Blood with the New Sensitive Abbott RealTime CMV Assay in the Era of the CMV International Standard

N. Schnepf, G. Socié, J. Molina, 2013, Journal of Clinical Microbiology.

Hepatosplenic Candidiasis in Patients With Hematological Malignancies: A 13-Year Retrospective Cohort Study

É. Oksenhendler, L. Adès, Q. Lisan, 2022, Open forum infectious diseases.

Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment.

R. Porcher, M. Robin, G. Socié, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation

M. Robin, G. Socié, N. Dhédin, 2020, Bone Marrow Transplantation.

Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation

R. Porcher, M. Robin, A. Toubert, 2012, Transplantation.

APRIL levels are associated with disease activity in human chronic graft-versus-host disease

M. Robin, M. Rybojad, M. Bagot, 2016, Haematologica.

CD19+CD5+ B cells and B1-like cells following allogeneic hematopoietic stem cell transplantation.

M. Robin, A. Toubert, M. Busson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tc1 clonal T cell expansion during chronic graft-versus-host disease-associated hypereosinophilia.

J. Cayuela, M. Robin, A. Toubert, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Severity Scores in Gastrointestinal Graft-Versus-Host Disease

R. Porcher, M. Robin, J. Mary, 2013, Transplantation.

Increased Incidence of Cytomegalovirus Retinitis After Allogeneic Hematopoietic Stem Cell Transplantation

M. Robin, H. Esperou, G. Socié, 2007, Transplantation.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP–EBMT

P. Chevallier, D. Blaise, J. Byrne, 2021, Bone Marrow Transplantation.

Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation.

A. Ganser, D. Navarro, J. Passweg, 2020, The Journal of infectious diseases.

R. Porcher, M. Robin, P. Chevallier, 2012 .

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

J. Byrne, C. Solano, E. Nicholson, 2023, Frontiers in Immunology.

Successful use of eculizumab in a patient with post‐transplant thrombotic microangiopathy

G. Socié, P. Coppo, V. Frémeaux-Bacchi, 2013, British journal of haematology.

A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor

M. Robin, G. Socié, T. Coman, 2019, Bone Marrow Transplantation.

Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases

J. Snowden, P. Ljungman, F. Ciceri, 2023, Journal of Autoimmunity.

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study

M. Robin, P. Chevallier, A. Thiébaut, 2023, British journal of haematology.

Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure

M. Robin, G. Socié, T. Coman, 2015, Annals of Hematology.

correspondence: Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis

M. Robin, H. Esperou, G. Socié, 2010, British journal of haematology.

[Major therapeutic advances and new perspectives in onco-hematology].

J. Bay, P. Verrelle, O. Tournilhac, 2013, Bulletin du cancer.

Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients

C. Delaugerre, M. Robin, G. Socié, 2022, Vaccine.

Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis

R. Porcher, M. Robin, G. Socié, 2012, Haematologica.

Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation.

M. Robin, M. Rybojad, M. Bagot, 2013, Blood.

Matthieu International Standard CMV Assay in the Era of the CMV e m with the New Sensitive Abbott RealTi Cytomegalovirus ( CMV ) in Whole Blood Fully Automated Quantification of

N. Schnepf, G. Socié, J. Molina, 2013 .

Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study

R. Porcher, M. Robin, R. Itzykson, 2018, Annals of Hematology.

A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients

M. Robin, G. Socié, S. Bretagne, 2022, Bone Marrow Transplantation.

Low to undetectable Omicron BQ.1.1 neutralization by patient’s sera a month after initiation of AZD7442 600mg

B. Autran, Y. Yazdanpanah, J. Gottenberg, 2023, Journal of Infection.

Incidence, risk factors and outcome of BK virus hemorrhagic cystitis following allogenic hematopoietic cell transplantation: a retrospective cohort study

M. Darmon, G. Socié, J. Molina, 2022, Bone Marrow Transplantation.

Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation.

A. Ganser, Peter Shaw, J. Byrne, 2023, The Journal of infectious diseases.

Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial

P. Feugier, S. Urien, A. Notarantonio, 2023, American journal of hematology.

Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

D. Lebeaux, M. Aljurf, O. Lortholary, 2021 .